Page last updated: 2024-08-17

methylene blue and Coronary Disease

methylene blue has been researched along with Coronary Disease in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Weissgerber, AJ	1
Bopp, C; Burhenne, J; Flechtenmacher, C; Goeppert, B; Schirmacher, P; Warth, A	1
Boullon, FJ; Bruno, GF; Degrange, MA; Del Mazo, CD; Griotti, JJ; Levin, RL; Taborda, DJ	1
Ganote, CE; Jennings, RB; Kloner, RA; Reimer, KA	1
Mahoney, JR	1

Reviews

1 review(s) available for methylene blue and Coronary Disease

Article	Year
Methylene blue for refractory hypotension: a case report. AANA journal, 2008, Volume: 76, Issue:4 Topics: Aged; Anaphylaxis; Anesthesia, General; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiopulmonary Bypass; Cefazolin; Coronary Artery Bypass; Coronary Disease; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hypotension; Male; Methylene Blue; Nitric Oxide Synthase; Patient Selection; Treatment Outcome	2008

Article

Year

Methylene blue for refractory hypotension: a case report.

AANA journal, 2008, Volume: 76, Issue:4

Topics: Aged; Anaphylaxis; Anesthesia, General; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiopulmonary Bypass; Cefazolin; Coronary Artery Bypass; Coronary Disease; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hypotension; Male; Methylene Blue; Nitric Oxide Synthase; Patient Selection; Treatment Outcome

2008

Trials

1 trial(s) available for methylene blue and Coronary Disease

Article	Year
Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. The Annals of thoracic surgery, 2004, Volume: 77, Issue:2 Topics: Cardiopulmonary Bypass; Cause of Death; Coronary Disease; Enzyme Inhibitors; Female; Heart Valve Diseases; Hemodynamics; Humans; Hypotension; Infusions, Intravenous; Male; Methylene Blue; Middle Aged; Nitric Oxide; Postoperative Complications; Risk Factors; Survival Rate; Systemic Inflammatory Response Syndrome; Vascular Resistance	2004

Article

Year

Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.

The Annals of thoracic surgery, 2004, Volume: 77, Issue:2

Topics: Cardiopulmonary Bypass; Cause of Death; Coronary Disease; Enzyme Inhibitors; Female; Heart Valve Diseases; Hemodynamics; Humans; Hypotension; Infusions, Intravenous; Male; Methylene Blue; Middle Aged; Nitric Oxide; Postoperative Complications; Risk Factors; Survival Rate; Systemic Inflammatory Response Syndrome; Vascular Resistance

2004

Other Studies

3 other study(ies) available for methylene blue and Coronary Disease

Article	Year
Turquoise to dark green organs at autopsy. Virchows Archiv : an international journal of pathology, 2009, Volume: 454, Issue:3 Topics: Aged; Autopsy; Chromatography, High Pressure Liquid; Coronary Disease; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Hypertension; Male; Methylene Blue; Pancreatectomy; Pancreatic Neoplasms; Postoperative Complications; Shock, Septic; Sleep Apnea, Obstructive; Tissue Distribution	2009
Distribution of coronary arterial flow in acute myocardial ischemia. Archives of pathology, 1975, Volume: 99, Issue:2 Topics: Acute Disease; Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Electrocardiography; Female; Fluorescent Dyes; Male; Methylene Blue; Myocardium; Papillary Muscles; Thiazoles	1975
Recovery of postischemic myocardial ATP levels and hexosemonophosphate shunt activity. Medical hypotheses, 1990, Volume: 31, Issue:1 Topics: Adenine Nucleotides; Adenosine Triphosphate; Coronary Disease; Humans; Methylene Blue; Models, Cardiovascular; Myocardium; Pentose Phosphate Pathway; Phosphoribosyl Pyrophosphate	1990